Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -0.50% is 700% below its 5-year average of 0.08%, near the low end of its 5-year range (-0.83%–1.20%).
As of the fiscal period ended Wednesday, December 31, 2025. 138.10% below its 12-month average of -0.21%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): 0.18%.
RETURN ON ASSETS (ROA)
-0.50%
RETURN ON ASSETS (ROA) AVG TTM
-0.21%
RETURN ON ASSETS (ROA) AVG 3Y
0.03%
RETURN ON ASSETS (ROA) AVG 5Y
0.08%
RETURN ON ASSETS (ROA) AVG 10Y
0.55%
RETURN ON ASSETS (ROA) AVG 15Y
0.37%
RETURN ON ASSETS (ROA) AVG 20Y
0.14%
CURRENT VS TTM AVG
-138.10%
CURRENT VS 3Y AVG
-1638.46%
CURRENT VS 5Y AVG
-700.00%
CURRENT VS 10Y AVG
-190.31%
CURRENT VS 15Y AVG
-234.58%
CURRENT VS 20Y AVG
-469.57%
SECTOR MEDIAN · HEALTHCARE
-32.27%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
+98.45%
vs the sector median at left
RadNet, Inc.
Market Cap
$5.53B
Return on Assets (ROA)
-0.50%
TTM Avg
-0.21%
3Y Avg
0.03%
5Y Avg
0.08%
Market Cap
$5.52B
Return on Assets (ROA)
-6.97%
TTM Avg
-6.55%
3Y Avg
-3.96%
5Y Avg
-3.96%
Market Cap
$5.61B
Return on Assets (ROA)
-20.67%
TTM Avg
-16.00%
3Y Avg
-20.09%
5Y Avg
-20.45%
Market Cap
$5.32B
Return on Assets (ROA)
-1.18%
TTM Avg
1.12%
3Y Avg
-15.90%
5Y Avg
-18.41%
Market Cap
$5.78B
Return on Assets (ROA)
-94.23%
TTM Avg
-58.97%
3Y Avg
-55.59%
5Y Avg
-44.06%
Market Cap
$5.79B
Return on Assets (ROA)
-31.62%
TTM Avg
-41.85%
3Y Avg
-50.05%
5Y Avg
-46.34%
Market Cap
$5.21B
Return on Assets (ROA)
-17.02%
TTM Avg
-21.01%
3Y Avg
-19.47%
5Y Avg
-13.88%
Market Cap
$5.21B
Return on Assets (ROA)
-5.44%
TTM Avg
-29.17%
3Y Avg
-28.46%
5Y Avg
-27.49%
Market Cap
$5.20B
Return on Assets (ROA)
4.94%
TTM Avg
1.92%
3Y Avg
-0.50%
5Y Avg
0.13%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| RadNet, Inc. (RDNT) | $5.53B | -0.50% | -0.21% | 0.03% | 0.08% |
| MiniMed Group, Inc. Common Stock (MMED)vs › | $5.52B | -6.97% | -6.55% | -3.96% | -3.96% |
| CG Oncology Inc. (CGON)vs › | $5.61B | -20.67% | -16.00% | -20.09% | -20.45% |
| PTC Therapeutics, Inc. (PTCT)vs › | $5.32B | -1.18% | 1.12% | -15.90% | -18.41% |
| Kodiak Sciences Inc. (KOD)vs › | $5.78B | -94.23% | -58.97% | -55.59% | -44.06% |
| Iovance Biotherapeutics, Inc. (IOVA)vs › | $5.79B | -31.62% | -41.85% | -50.05% | -46.34% |
| CRISPR Therapeutics AG (CRSP)vs › | $5.21B | -17.02% | -21.01% | -19.47% | -13.88% |
| Travere Therapeutics, Inc. (TVTX)vs › | $5.21B | -5.44% | -29.17% | -28.46% | -27.49% |
| Sotera Health Company (SHC)vs › | $5.20B | 4.94% | 1.92% | -0.50% | 0.13% |
| Doximity, Inc. (DOCS)vs › | $5.20B | 15.41% | 17.55% | 14.67% | 15.71% |
ROA
-0.5%
ROE
-1.9%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -0.50% |
| 2024-12-31 | 0.08% |
| 2023-12-31 | 0.11% |
| 2022-12-31 | 0.44% |
| 2021-12-31 | 1.20% |
| 2020-12-31 | -0.83% |
| 2019-12-31 | 0.90% |
| 2018-12-31 | 2.91% |
| 2017-12-31 | 0.01% |
| 2016-12-31 | 0.85% |
| 2015-12-31 | 0.92% |
| 2014-12-31 | 0.19% |
| 2013-12-31 | 0.29% |
| 2012-12-31 | 9.02% |
| 2011-12-31 | 1.17% |
| 2010-12-31 | -2.38% |
| 2009-12-31 | -0.47% |
| 2008-12-31 | -2.59% |
| 2007-12-31 | -4.18% |
| 2006-10-31 | -5.25% |
| 2005-10-31 | -2.64% |
| 2004-10-31 | -11.60% |
| 2003-10-31 | -1.60% |
| 2002-10-31 | -3.66% |
| 2001-10-31 | 11.29% |
| 2000-10-31 | 2.86% |
| 1999-10-31 | -12.47% |
| 1998-10-31 | -46.80% |
| 1997-10-31 | -0.87% |
| 1996-10-31 | -7.89% |
